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Antibody precipitation as capture step is an alternative technology to chromatography, because it is a fully 
continuous method. Bioreactor effluent from a perfusion reactor can be directly processed without surge tanks 
and the method can be combined with flocculation. We hypothesized that a continuous precipitation and 
flocculation reactor can be operated under non-steady state conditions. This will allow the design of reactors 
with extremely short residence time. In batch precipitation steady stats is achieved when the floc size does not 
change over time.  We developed a continuous capture step for antibodies by protein precipitation with PEG 
6000. Precipitation and re-solubilization conditions were established by a high throughput approach in batch 
mode. Continuous precipitation was realized by a tubular reactor design containing static mixers.  The particle 
size distribution of the product precipitate was on-line monitored by Focused Beam Reflectance Measurement 
(FBRM) in a flow cell. Various hold times (2 to 20 minutes) of the cell culture harvest and different product 
concentrations were used to simulate changes during continuous fermentation. Precipitate was collected and 
separation was performed by centrifugation. High molecular weight impurities were reduced by a factor of 5 to 
10, yields of 90% and purity increase by a factor of 2.5 were achieved according to size exclusion 
chromatography. Using FBRM we were able to demonstrate that different residence times during precipitation 
do not significantly change the particle size distribution. Stable performance concerning product quality (yield, 
purity and high molecular weight impurities) for different residence times were demonstrated for up to 90 
minutes runtime. The influence of product concentration on the precipitate was quantified by FBRM. We 
demonstrated that protein precipitation is a robust and feasible capture step for mAb purification that does not 
require steady state conditions and that such continuous reactors are not compulsory operated at steady state 
conditions. Optimization potential was identified and can be realized during upscale, and higher yields and 
better performance can be reasonably expected for larger scales. 
